Chee-Ruey Hsieh – författare

The pharmaceutical industry worldwide is a rapidly burgeoning industry contributing to growth of gross domestic product and employment. Technological change in this field has been very rapid, with many new products being introduced. For this reason in part, health care budgets throughout the world have increased dramatically, eliciting growing pressures for cost containment. This book explores four important issues in pharmaceutical innovations: (1) the industry structure of pharmaceutical innovation; (2) incentives for correcting market failures in allocating resources for research and development; (3) competition and marketing; and (4) public evaluation of the benefits and costs of innovation. The lessons are applicable to countries all over the world, at all levels of economic development. By discussing existing evidence this book proposes incentive arrangements to accomplish social objectives.

Currently developed countries pay much more attention to harmfully addictive substances than developing countries. However, the experience of developed countries is very relevant to the developing world since substance abuse is likely to impose a continually increasing burden of disease in this region in the near future. This book extends the frontiers of research on the economics of substance use and abuse in a variety of extremely significant ways. It focuses on the determinants and consequences of the consumption of cigarettes, alcohol, betel quid, and illicit drugs in the United States, Great Britain and Taiwan. The authors use a variety of empirical techniques to examine the roles of price, advertising, risk perception, time preference and forward-looking behaviour in consumption decisions and the effects of these decisions on labour market outcomes, unintended pregnancies and criminal violence.Economic Analysis of Substance Use and Abuse will be required reading for scholars of economic development and health economics.

In order to control ever-increasing health care expenditure, Western and Asian countries are seeking to develop more efficient health care models. Studies on health care that focus specifically on Asian countries are rare, rendering this a unique and welcome addition to the literature. This book presents quantitative research on various aspects of health care reform and health policy in Asia-Pacific countries such as China, Indonesia, Japan, South Korea, Taiwan, and the US - nations diverse in their economic development, social demographic structure and health care expenditures. The book's main topic for discussion is the role of both government and health insurers in funding health care. The implementation of community-based, supplemental and national health insurance is explored, as are grants and the financing of hospitals and care for the elderly. The effectiveness of education as an input to health investment and the rehabilitation of patients are also examined. Aiming to close the gap between the existing economics research and the rapid pace of the development of Asian health care markets, this unique and timely book is a must read for policymakers, researchers, academics and students with a special interest in health economics, policies and services.

This book uses an economic approach to analyze the socioeconomic causes and consequences of mental health disorders in China, with a special focus on mental depression.